Amid a broader push to beef up cell and gene therapy manufacturing capacity in Europe, Novartis has opened the doors to a €40 ...

The cuts at two Massachusetts plants follow further site closures and layoffs across the company over the past few years.

Despite recent evidence of its financial turnaround, Thermo Fisher’s layoff spree will continue into 2025. | Despite recent ...

Job cuts in Cambridge and Plainville are the second workforce reduction planned for the facilities in the past three months.

Researchers have demonstrated, for the first time in the world using mice, the ability to overcome significant challenges in ...

GSK is prioritizing development of its hepatitis B treatment bepirovirsen as the pharma ends work on another potential ...

The virus that causes eastern equine encephalitis, or EEE, has evolved to infect mosquitoes. To be able to spread between ...

Tax advantages offered by PEA-PME and PEA are only available to French residents. *Shares of European companies with fewer than 5,000 employees and an annual revenue of less than €1.5 billion or total ...

Oxford, UK – 5 February 2025: OXB (LSE: OXB), a quality and innovation-led cell and gene therapy CDMO, today announces the appointment of Jefferies International Limited ("Jefferies") as its Joint ...